![]() |
市場調査レポート
商品コード
1687672
腎機能検査の市場規模、シェア、成長分析:検査タイプ別、製品別、エンドユーザー別、地域別 - 産業予測、2025年~2032年Kidney Function Test Market Size, Share, and Growth Analysis, By Test Type (Blood Tests, Urine Tests), By Product (Dipsticks, Reagents), By End User, By Region - Industry Forecast 2025-2032 |
||||||
|
腎機能検査の市場規模、シェア、成長分析:検査タイプ別、製品別、エンドユーザー別、地域別 - 産業予測、2025年~2032年 |
出版日: 2025年03月18日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3~5営業日
|
腎機能検査の世界市場規模は2023年に9億5,759万米ドルとなり、予測期間(2025年~2032年)のCAGRは6.5%で、2024年の10億1,983万米ドルから2032年までには16億8,782万米ドルに成長する見通しです。
腎機能検査市場は、大手企業による投資の増加や腎臓ケアにおける研究開発努力の高まりによって力強い成長を遂げています。腎臓病の有病率の上昇により、診断法や治療法の改善が必要となり、ヘルスケアにおける積極的な対策が促されています。政府のイニシアチブはこの勢いをさらに増幅させ、イノベーションを支援する環境を作り出しています。注目すべき進歩は、2022年3月に発売されたNova Biomedicalの画期的なツールで、従来の病院環境以外のPOCT(Point-of-Care Testing)環境での早期疾患検出と腎機能スクリーニングを通じて腎臓ケアに革命を起こすよう設計されています。地域医療センター、薬局、在宅検査など多様な場所での有効性を実証する臨床研究は、この技術が診断能力を強化し、最終的に患者の転帰改善と腎臓の健康管理への積極的なアプローチにつながる可能性を強調しています。
Global Kidney Function Test Market size was valued at USD 957.59 million in 2023 and is poised to grow from USD 1019.83 million in 2024 to USD 1687.82 million by 2032, growing at a CAGR of 6.5% during the forecast period (2025-2032).
The Kidney function test market is experiencing robust growth driven by increased investments from major players and heightened research and development efforts in kidney care. The rising prevalence of kidney diseases necessitates improved diagnostics and treatment options, prompting proactive measures in healthcare. Government initiatives further amplify this momentum, creating a supportive environment for innovations. A notable advancement is Nova Biomedical's groundbreaking tool, launched in March 2022, designed to revolutionize kidney care through early disease detection and renal function screening in Point-of-Care Testing (POCT) settings outside traditional hospital environments. Clinical studies demonstrating its effectiveness in diverse locations-including community health centers, pharmacies, and home testing-highlight this technology's potential to enhance diagnostic capabilities, ultimately leading to better patient outcomes and a proactive approach to kidney health management.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Kidney Function Test market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Kidney Function Test Market Segments Analysis
Global Kidney Function Test Market is segmented by Test Type, Product, End User and region. Based on Test Type, the market is segmented into Blood Tests, Urine Tests, Imaging Tests and Kidney Biopsy. Based on Product, the market is segmented into Dipsticks, Reagents and Disposables. Based on End User, the market is segmented into Hospitals, Diagnostic Laboratories, Research Laboratories and Institutes and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Kidney Function Test Market
The Global Kidney Function Test market is set to experience significant growth, fueled by continuous technological advancements. A prime example is the innovative smart system launched by Bloom Diagnostics in August 2022, designed to detect a wide range of medical conditions. The introduction of the Bloom Kidney Test has marked a transformative step in kidney health evaluation, as it quantitatively assesses cystatin C levels in the bloodstream, thereby enabling a more accurate evaluation of the Glomerular Filtration Rate (GFR) to assess kidney function. This test offers a thorough analysis categorized into three classifications-normal function, mildly decreased function, and decreased function-providing essential insights into overall kidney health.
Restraints in the Global Kidney Function Test Market
The expanding Global Kidney Function Test market encounters notable challenges primarily due to the elevated costs linked to these diagnostic procedures, particularly in emerging and underdeveloped countries. This issue of affordability restricts the widespread utilization of these vital tests, limiting equitable access to essential healthcare diagnostics. Furthermore, the low adoption rates in these regions contribute to the ongoing disparity in early detection and treatment of kidney-related conditions, ultimately affecting patient outcomes. Addressing these obstacles is crucial to enhance accessibility and improve health literacy, ensuring that individuals in less affluent areas receive timely and necessary medical attention for kidney health issues.
Market Trends of the Global Kidney Function Test Market
The Global Kidney Function Test market is witnessing significant momentum, primarily fueled by the rising demand for home diagnostics and the adoption of innovative technologies such as digital urinalysis. This shift towards more accessible and convenient healthcare solutions reflects broader consumer preferences for proactive health management. Companies like Healthy.io are capitalizing on this trend by introducing FDA-cleared at-home smartphone urinalysis tests specifically designed for kidney function assessment, enabling users to monitor their health easily. As patients increasingly seek user-friendly diagnostics that cater to their needs, the market is poised for substantial growth, driven by ongoing advancements in telemedicine and digital health platforms.